Limpidex

Lansoprazole, the active ingredient in Limpidex, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcers and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Limpidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Duodenal ulcer: promotes ulcer healing by suppressing gastric acid. - Gastric ulcer: aids in ulcer resolution through acid reduction. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion in this rare condition.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional, may improve with food. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: occasional.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fracture risk: long‑term use may affect bone density. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: use caution in liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for infection: prolonged acid suppression may increase risk of gastrointestinal infections. - Pregnancy and lactation: discuss risks with a healthcare professional. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lansoprazole may alter the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate: higher serum levels, watch for toxicity. - Digoxin: altered plasma concentration, adjust dose if needed.